Everpure shorts build quietly as analysts lift targets ahead of November earnings

Everpure heads into its November 18 earnings date with short sellers quietly rebuilding positions against a backdrop of broad analyst optimism and a stock that just posted its best single-day gain in weeks.

The short interest story is modest in absolute terms but the direction is worth noting. At 2.7% of free float, the position is not large enough to represent aggressive conviction. Yet shorts have grown 13% over the past week and nearly 17% over the past month, a steady accumulation that has been running against the grain of the stock's 3.3% weekly gain and a 6.5% single-day pop on October 26. The borrow market remains wide open: availability is effectively unconstrained, with over 230 million shares available to lend against fewer than 9 million shorted. Cost to borrow is 0.45%, up around 16% on the week but still negligible in absolute terms. The ORTEX short score of 31.8 places Everpure comfortably in the lower half of the short-pressure universe. This is not a squeeze setup. It looks more like a measured hedge being built into a known catalyst.

Options positioning adds a layer of caution without crossing into alarm. The put/call ratio of 0.86 runs modestly above its 20-day average of 0.82, a z-score of roughly 0.9, not the kind of defensive extreme that signals real fear. Notably, the PCR has drifted higher over the past three weeks from a low near 0.71 in mid-September to a reading close to the 52-week high of 0.90 touched on October 16. The move is gradual rather than sharp, consistent with institutional players adding hedges into an earnings event rather than outright bearish positioning.

The Street remains firmly in the bull camp, though with some nuance on valuation. All 12 analysts tracked carry buy-equivalent ratings. Guggenheim raised its target to $215 on October 12, a sharp step up from $150 and by far the most aggressive number on the board. Needham followed with a move to $185 earlier in the month. The mean target of $151 now sits modestly above the current price of $131, and the gap reflects the fact that many targets were set before the stock's recent run. The bull case centres on booked hyperscaler and neocloud contracts extending well into fiscal 2029, an estimated hyperscaler opportunity rising from roughly 60 exabytes in 2027 to close to 140 by 2029, and margin expansion toward 24 to 26% in fiscal 2028. Bears point to the fragility of memory price inflation, long enterprise sales cycles, and the risk that subscription ARR trends disappoint if AI-driven demand proves less durable than the models assume. The EV/EBITDA multiple of 24x has expanded about 3 points over the past month, and the PE of 33.5x reflects a stock that is priced for execution. Factor scores back up the momentum angle: 90-day EPS momentum ranks in the 93rd percentile, and 12-month forward EPS growth improvement ranks 78th. Value scores are weak, with the EV/EBIT factor ranking just 2nd percentile across the universe.

Ownership and insider activity carry a divergent signal worth watching. On the institutional side, BlackRock added over 4.4 million shares in the September quarter to push its stake to 10.4% of shares outstanding. State Street added more than 4 million shares in the same period. Those are meaningful flows into a stock with a $44 billion market cap. The insider picture tells a different story. Director Scott Dietzen sold roughly $8.5 million of stock on October 14, in open-market transactions not covered by a pre-arranged 10b5-1 plan. Chief Visionary Officer John Colgrove sold approximately $10.6 million across multiple transactions on the same date, those under a 10b5-1 plan and therefore carrying lower signal weight. Net insider activity over the past 90 days totals negative $92.6 million across 647,000 shares. The contrast between institutional buying and insider selling is the most interesting tension in the ownership data.

One structural tailwind has already been locked in. Everpure was added to the S&P 500 and deleted from the S&P MidCap 400 at the September 2026 annual review, effective September 21. The index inclusion generated an estimated $6.5 billion of forced buying by trackers, equivalent to roughly 18.9 days of normal trading volume. That rebalance is now behind the stock, and the passive bid that came with it has been absorbed.

After the September earnings print, the stock jumped roughly 10% on the day and nearly 18% over the following five sessions, a reaction that set a high bar for November 18. What to watch between now and then is whether the steady accumulation of short positions continues at the same pace, and whether the gap between the Guggenheim $215 target and the mean $151 starts to close as other firms update their models.